Terms: = Breast cancer AND NCOR1, hCIT529I10, 9611, ENSG00000141027, N-CoR, MGC104216, TRAC1, O75376, hN-CoR, KIAA1047
86 results:
1. Association of Germline Variation in Driver Genes with breast cancer Risk in Chilean Population.
Morales-Pison S; Tapia JC; Morales-González S; Maldonado E; Acuña M; Calaf GM; Jara L
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003265
[TBL] [Abstract] [Full Text] [Related]
2. Nonlobular Invasive breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Derakhshan F; Da Cruz Paula A; Selenica P; da Silva EM; Grabenstetter A; Jalali S; Gazzo AM; Dopeso H; Marra A; Brown DN; Ross DS; Mandelker D; Razavi P; Chandarlapaty S; Wen HY; Brogi E; Zhang H; Weigelt B; Pareja F; Reis-Filho JS
Mod Pathol; 2024 Feb; 37(2):100375. PubMed ID: 37925055
[TBL] [Abstract] [Full Text] [Related]
3. A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi S; Tsilidis KK; Dossus L; Rinaldi S; Weiderpass E; Antoniussen CS; Dahm CC; Tjønneland A; Mellemkjær L; Katzke V; Kaaks R; Schulze MB; Masala G; Grioni S; Panico S; Tumino R; Sacerdote C; May AM; Monninkhof EM; Quirós JR; Bonet C; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Rosendahl AH; Stocks T; Perez-Cornago A; Tin Tin S; Heath AK; Aglago EK; Peruchet-Noray L; Freisling H; Riboli E
BMC Cancer; 2023 Jun; 23(1):562. PubMed ID: 37337133
[TBL] [Abstract] [Full Text] [Related]
4. breast cancer plasticity is restricted by a LATS1-ncor1 repressive axis.
Aylon Y; Furth N; Mallel G; Friedlander G; Nataraj NB; Dong M; Hassin O; Zoabi R; Cohen B; Drendel V; Salame TM; Mukherjee S; Harpaz N; Johnson R; Aulitzky WE; Yarden Y; Shema E; Oren M
Nat Commun; 2022 Nov; 13(1):7199. PubMed ID: 36443319
[TBL] [Abstract] [Full Text] [Related]
5. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
[TBL] [Abstract] [Full Text] [Related]
6. FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway.
Zhang X; Zhang R; Hou C; He R; Wang QS; Zhou TH; Li XQ; Zhai QL; Feng YM
J Biol Chem; 2022 Jul; 298(7):102082. PubMed ID: 35660418
[TBL] [Abstract] [Full Text] [Related]
7. How accurate is frozen section pathology compared to permanent pathology in detecting involved margins and lymph nodes in breast cancer?
Namdar ZM; Omidifar N; Arasteh P; Akrami M; Tahmasebi S; Nobandegani AS; Sedighi S; Zangouri V; Talei A
World J Surg Oncol; 2021 Sep; 19(1):261. PubMed ID: 34470649
[TBL] [Abstract] [Full Text] [Related]
8. Synchronous detection of pancreatic adenocarcinoma and paraganglioma in a Whipple resection specimen.
Aaquist T; Dembic M; Thomassen M; de Stricker K; Bertelsen M; Christensen LG; Mortensen MB; Detlefsen S
Pathol Res Pract; 2021 Oct; 226():153590. PubMed ID: 34454393
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear translocation of MRTFA in MCF7 breast cancer cells shifts ERα nuclear/genomic to extra-nuclear/non genomic actions.
Jehanno C; Percevault F; Boujrad N; Le Goff P; Fontaine C; Arnal JF; Primig M; Pakdel F; Michel D; Métivier R; Flouriot G
Mol Cell Endocrinol; 2021 Jun; 530():111282. PubMed ID: 33894309
[TBL] [Abstract] [Full Text] [Related]
10. Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical breast cancer Models: Integrative Genomics and Transcriptomics.
Pandey K; Lee E; Park N; Hur J; Cho YB; Katuwal NB; Kim SK; Lee SA; Kim I; An HJ; Hwang S; Moon YW
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33504001
[TBL] [Abstract] [Full Text] [Related]
11. Identifying Genomic Alterations in Patients With Stage IV breast cancer Using MammaSeq: An International Collaborative Study.
Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
[TBL] [Abstract] [Full Text] [Related]
12. Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
Srour AM; Ahmed NS; Abd El-Karim SS; Anwar MM; El-Hallouty SM
Bioorg Med Chem; 2020 Sep; 28(18):115657. PubMed ID: 32828424
[TBL] [Abstract] [Full Text] [Related]
13. Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
van Geelen CT; Savas P; Teo ZL; Luen SJ; Weng CF; Ko YA; Kuykhoven KS; Caramia F; Salgado R; Francis PA; Dawson SJ; Fox SB; Fellowes A; Loi S
Breast Cancer Res; 2020 Aug; 22(1):91. PubMed ID: 32811538
[TBL] [Abstract] [Full Text] [Related]
14. Exposure-response analysis of endoxifen serum concentrations in early-breast cancer.
Sanchez-Spitman AB; Moes DAR; Swen JJ; Dezentjé VO; Lambrechts D; Neven P; Gelderblom H; Guchelaar HJ
Cancer Chemother Pharmacol; 2020 Jun; 85(6):1141-1152. PubMed ID: 32468081
[TBL] [Abstract] [Full Text] [Related]
15. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
[TBL] [Abstract] [Full Text] [Related]
16. Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory breast cancer.
Winn JS; Hasse Z; Slifker M; Pei J; Arisi-Fernandez SM; Talarchek JN; Obeid E; Baldwin DA; Gong Y; Ross E; Cristofanilli M; Alpaugh RK; Fernandez SV
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075053
[TBL] [Abstract] [Full Text] [Related]
17. The Association of Modifiable breast cancer Risk Factors and Somatic Genomic Alterations in breast Tumors: The cancer Genome Atlas Network.
Heng YJ; Hankinson SE; Wang J; Alexandrov LB; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; Eliassen AH; Tamimi RM; Kraft P
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):599-605. PubMed ID: 31932411
[TBL] [Abstract] [Full Text] [Related]
18. ER-Negative breast cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
[TBL] [Abstract] [Full Text] [Related]
19. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
20. Predicting breast cancer by Applying Deep Learning to Linked Health Records and Mammograms.
Akselrod-Ballin A; Chorev M; Shoshan Y; Spiro A; Hazan A; Melamed R; Barkan E; Herzel E; Naor S; Karavani E; Koren G; Goldschmidt Y; Shalev V; Rosen-Zvi M; Guindy M
Radiology; 2019 Aug; 292(2):331-342. PubMed ID: 31210611
[TBL] [Abstract] [Full Text] [Related]
[Next]